Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 12-1991 | 12-1990 | 12-1989 | 12-1988 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,468 | 295 | 38 | 38 | 0 |
| TOTAL | $2,468 | $295 | $38 | $38 | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 10,049 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 8,660 | 2,913 | 534 | 534 | 0 |
| TOTAL | $18,709 | $2,913 | $534 | $534 | $N/A |
| Total Assets | $21,177 | $3,208 | $571 | $571 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,037 | 491 | 615 | 615 | N/A |
| Accounts payable and accrued liabilities | 1,538 | 502 | 658 | 658 | 0 |
| Accrued Expenses | 2,547 | 263 | 231 | 231 | N/A |
| TOTAL | $5,121 | $1,256 | $1,504 | $1,504 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 866 | 224 | 13 | 13 | 0 |
| TOTAL | $5,766 | $224 | $13 | $13 | $N/A |
| Total Liabilities | $10,887 | $1,480 | $1,517 | $1,517 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 172 | 11 | 11 | 11 | N/A |
| TOTAL | $83,101 | $23,794 | $9,924 | $9,924 | $N/A |
| Total Liabilities And Equity | $93,988 | $25,274 | $11,441 | $11,441 | $0 |